Ciltacabtagene autoleucel (cilta-cel; Carvykti) for multiple myeloma has a new boxed warning for immune effector ...

The FDA has adjusted the label of Johnson & Johnson and Legend Biotech’s Carvykti, warning patients and doctors that use of ...

Common causes of low back pain include muscle strain, trauma, osteoporosis, and autoimmune disorders.

Severe gastrointestinal inflammation could occur in 2 percent to 3 percent of patients who receive Carvykti, the FDA has informed patients and doctors.

The U.S. Food and Drug Administration (FDA) has updated the safety labeling for Carvykti, the multiple myeloma therapy ...

DURHAM, N.C. -- Researchers at Duke University have shown that blocking an enzyme involved in iron regulation not only kills multiple myeloma cancer cells, but also increases the effectiveness of ...

Infections are a major cause of morbidity and mortality in MM due to profound immunosuppression from the disease and its treatments. Vaccination, despite impaired responses, reduces respiratory ...

Renowned Bhojpuri and Maithili singer Sharda Sinha, fondly known as 'Bihar Kokila', passed away at 72 due to complications ...